CASTORIA, Gabriella
 Distribuzione geografica
Continente #
EU - Europa 10.111
NA - Nord America 6.898
AS - Asia 4.601
SA - Sud America 595
Continente sconosciuto - Info sul continente non disponibili 437
AF - Africa 53
OC - Oceania 12
Totale 22.707
Nazione #
US - Stati Uniti d'America 6.655
RU - Federazione Russa 6.024
SG - Singapore 1.461
IT - Italia 1.155
IE - Irlanda 1.022
CN - Cina 996
HK - Hong Kong 586
BR - Brasile 500
UA - Ucraina 475
VN - Vietnam 465
GB - Regno Unito 460
IN - India 324
DE - Germania 316
TR - Turchia 291
KR - Corea 219
FI - Finlandia 184
SE - Svezia 132
FR - Francia 102
JP - Giappone 91
CA - Canada 83
GR - Grecia 78
BE - Belgio 42
AR - Argentina 32
BD - Bangladesh 29
MX - Messico 28
NL - Olanda 26
PK - Pakistan 22
HN - Honduras 21
PR - Porto Rico 18
AT - Austria 16
ID - Indonesia 16
IQ - Iraq 16
CO - Colombia 15
JO - Giordania 15
SV - El Salvador 15
CR - Costa Rica 14
NI - Nicaragua 14
EC - Ecuador 13
GP - Guadalupe 13
ES - Italia 12
PL - Polonia 12
VE - Venezuela 11
GT - Guatemala 10
MA - Marocco 9
PY - Paraguay 9
TT - Trinidad e Tobago 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
AU - Australia 7
BG - Bulgaria 7
IR - Iran 7
KE - Kenya 7
PH - Filippine 7
TH - Thailandia 7
DZ - Algeria 6
EG - Egitto 6
JM - Giamaica 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CL - Cile 5
CW - ???statistics.table.value.countryCode.CW??? 5
HR - Croazia 5
HU - Ungheria 5
IL - Israele 5
LT - Lituania 5
NO - Norvegia 5
PE - Perù 5
PT - Portogallo 5
RO - Romania 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
NZ - Nuova Zelanda 4
PA - Panama 4
UY - Uruguay 4
BY - Bielorussia 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
NP - Nepal 3
SN - Senegal 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BM - Bermuda 2
CI - Costa d'Avorio 2
DK - Danimarca 2
KG - Kirghizistan 2
KZ - Kazakistan 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BN - Brunei Darussalam 1
CH - Svizzera 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
Totale 22.266
Città #
Moscow 2.186
Dublin 1.015
San Jose 864
Jacksonville 723
Singapore 723
Chandler 714
Santa Clara 658
Hong Kong 573
Ashburn 459
Council Bluffs 358
Bengaluru 287
Seoul 203
Ann Arbor 202
Beijing 179
Hefei 163
Ho Chi Minh City 156
Caserta 148
Princeton 148
Naples 137
Hanoi 124
Boardman 118
Istanbul 104
Milan 104
Medford 100
Roxbury 92
Los Angeles 89
Bremen 82
Dallas 80
Woodbridge 75
Wilmington 74
San Mateo 54
The Dalles 47
São Paulo 44
Cambridge 42
Nanjing 42
Rome 41
Brussels 40
Helsinki 38
New York 37
Da Nang 36
Houston 34
Aversa 33
Napoli 33
Munich 30
Jinan 29
Des Moines 25
Mountain View 23
Turku 23
Miano 22
Rio de Janeiro 22
Orem 21
Pozzuoli 20
Frankfurt am Main 18
Tokyo 18
London 17
Norwalk 17
Shanghai 17
Kunming 16
Phoenix 16
Shenyang 16
North Bergen 15
San Salvador 15
Seattle 15
Guangzhou 14
Amman 13
Belo Horizonte 13
Chennai 13
Chicago 13
Haiphong 13
Managua 13
Amsterdam 12
Atlanta 12
Brooklyn 12
Nanchang 12
Toronto 12
Afragola 11
Biên Hòa 11
Düsseldorf 11
Hanover 11
Hải Dương 11
Queens 11
Vienna 11
Catanzaro 10
Denver 10
Memphis 10
Salerno 10
Dhaka 9
Guatemala City 9
Montreal 9
Somma Vesuviana 9
Tashkent 9
Tricesimo 9
Zhengzhou 9
Boston 8
Cabo Frio 8
Charlotte 8
Dearborn 8
Falkenstein 8
Giugliano in Campania 8
Redwood City 8
Totale 12.242
Nome #
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 314
'Role of PI3-K signaling in steroid action’ 221
CROSS-TALK BETWEEN ANDROGEN RECEPTOR AND NERVE GROWTH FACTOR RECEPTOR IN PROSTATE CANCER CELLS: IMPLICATIONS FOR A NEW THERAPEUTIC APPROACH. 209
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 205
Androgen regulation of motility in fibroblasts 203
Calmodulin-stimulated estradiol receptor-tyrosine kinase I 201
Effect of new androgen receptor antagonists (SARMs) in the treatment of human prostate cancer. 200
Androgen receptor targeted conjugate for bimodal photodynamic therapy of prostate cancer in vitro. 198
Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells 198
Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors 197
Breast cancer stem cells: The role of sex steroid receptors 196
Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. 195
Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. 194
CROSS TALK BETWEEN ANDROGEN RECEPTOR/ FILAMIN A AND TrkA REGULATES NEURITE OUTGROWTH IN PC12 CELLS 190
Activation-inactivation of hormone binding sites of the oestradiol-17 beta receptor is a multiregulated process 189
Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth 188
Analysis of the Androgen Receptor/Filamin A Complex in Stromal Cells 187
Crosstalk between EGFR and extranuclear steroid receptors. 186
Androgen-induced cell migration: role of androgen receptor/filamin A association. 186
Patologia Generale 184
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. 182
Protein tyrosine phosphorylation and estradiol action 182
Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer 182
Discovering New Targets in Triple-Negative Breast Cancer (TNBC): The Androgen Receptor and the Estrogen Receptor β. 180
Analysis of androgen receptor rapid actions in cellular signaling pathways: receptor/src association 180
Integrating signals between cAMP and MAPK pathways in breast cancer 178
Sex steroid hormones act as growth factors 178
Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor a alpha tyrosine-phosphorylated peptide 177
Targeting rapid action of sex-steroid receptors in breast and prostate cancers. 177
High-throughput screening identifies kinase inhibitors that increase dual AAV vectors transduction in vitro and in mouse retina. 177
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 176
Activation of the Src/Ras/Erks pathway is required for steroid-induced S-phase entry of human mammary carcinoma-derived cells 175
Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications. 175
Agri-Food By-Products in Cancer: New Targets and Strategies. 174
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 174
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells through AR/Src/PI3-K Complex Assembly. 173
cAMP pathway in differentiating myoblast 172
Action of vanadate on estrogen dependent MCF-7 cells. 172
Advances in Rapid Sex-Steroid Action New Challenges and New Chances in Breast and Prostate Cancers 170
'Steroid-activated PI3-K pathway in target cells'. 169
Differentiation of H9c2 cardiomyoblasts: The role of adenylate cyclase system. 168
Activation of c-src/p21ras/erks pathway by steroids and its role in human mammary cancer cell lines. 167
THE DUAL ROLE OF ANDROGEN RECEPTOR IN MESENCHYMAL CELLS. 166
Rapid signalling pathway activation by androgens in epithelial and stromal cells 166
A New Avenue toward Androgen Receptor Pan-antagonists: C2 Sterically Hindered Substitution of Hydroxy-propanamides. 166
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 166
Estradiol activation of human colon carcinoma-derived Caco-2 cell growth 165
EXTRA-NUCLEAR PARTNERS OF ANDROGEN RECEPTOR: AT THE CROSSROADS OF PROLIFERATION, MIGRATION AND NEURITOGENESIS. 165
Role of the Androgen Receptor in Gender-Related Cancers. 162
Androgens and NGF Mediate the Neurite-Outgrowth through Inactivation of RhoA. 161
The Androgen Regulation of Matrix Metalloproteases in Prostate Cancer and Its Related Tumor Microenvironment. 159
RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer. 159
In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor 159
ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities 159
Src is an initial target of sex steroid hormone action. 158
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer. 158
Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells. 157
Cell proliferation regulated by estradiol receptor: therapeutic implications. 157
Binary switch between adjacent marks in histone H3 directs productive transcription in estrogen-induced breast cancer cells upon cyclical creation of ROS. 157
Communication between cells: exosomes as a delivery system in prostate cancer. 157
Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer 155
A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells 153
Androgens as the “old age stick” in skeletal muscle (Correction: Androgens as the “old age stick” in skeletal muscle) 152
Steroid signaling activation and intracellular localization of sex steroid receptors 152
Phosphorylation on tyrosine of oestradiol-17 beta receptor in uterus and interaction of oestradiol-17 beta and glucocorticoid receptors with antiphosphotyrosine antibodies 151
Estrogens Modulate Somatostatin Receptors Expression and Synergizes With the Somatostatin Analog Pasireotide in Prostate Cells 150
The Role of the Androgen Receptor in Skeletal Muscle and Its Utility as a Target for Restoring Muscle Functions. 150
Filamin A cooperates with the androgen receptor in preventing skeletal muscle senescence 148
Control of cell proliferation by estradiol and protein tyrosine phosphorilation. 147
Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. 146
Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines. 145
Prostate cancer stem cells: the role of androgen and estrogen receptors. 144
Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models. 143
Biochemical and Pathophysiological Premises to Positron Emission Tomography With Choline Radiotracers. 143
Non-Steroidal Androgen Receptor Ligands: Versatile Syntheses and Biological Data. 142
Le basi cellulari e molecolari delle malattie per le lauree triennali e magistrali 142
Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholeness. 141
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells 141
Alterazioni del Sistema Endocrino- Sezione E " Fisiopatologia Molecolare degli Organi e dei sistemi"- 141
Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells. 141
Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. 140
THE ROLE OF THE ANDROGEN RECEPTOR IN SKELETAL MUSCLE SENESCENCE. 138
Filamin A in triple negative breast cancer. 138
Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells. 136
New insights and emerging therapeutic approaches in prostate cancer. 136
Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance 135
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol receptor complex in MCF-7 cells 135
The role of androgen receptor/filamin A association in androgen-induced cell migration 135
Searching for a putative mechanism of tumor-promoting function of RIZ2 in cancer models 135
ICI 164,384 e ICI 182,780 prevengono l’atività proliferativa del recettore dell’estradiolo mediata dalla fosforilazione delle proteine. 134
Inhibitors targeting the Src/Ras/Erks pathway prevent cancer cell S-phase entry induced by steroids. 133
Targeting androgen receptor/Src complex impairs the aggressive phenotype of human fibrosarcoma cells. 133
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models. 133
Dephosphorylation of oestradiol nuclear receptor in vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens 132
Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome. 131
Novel aspects of signalling activation by steroid hormones in target cells. 131
Non-genomic action of steroid hormones: More questions than answers 131
The role of androgen receptor in stromal cells. 130
Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells. 129
Acetylation/methylation at lysine 9 in histone H3 as a mark of nucleosome asymmetry in human somatic breast cells 129
Totale 16.397
Categoria #
all - tutte 73.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022922 0 0 0 29 338 32 28 28 28 86 78 275
2022/20232.338 155 71 28 243 242 228 11 174 1.045 24 61 56
2023/2024979 105 39 33 86 282 48 40 55 16 35 96 144
2024/20252.558 14 21 33 171 393 355 374 192 330 278 210 187
2025/202610.801 505 761 466 391 877 5.639 620 545 433 279 152 133
2026/20271.657 53 232 634 738 0 0 0 0 0 0 0 0
Totale 22.707